The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) aims to develop a framework for functional mapping the human body with cellular resolution to enhance our understanding of cellular organization-function. HuBMAP will accelerate the development of the next generation of tools and techniques to generate 3D tissue maps using validated high-content, high-throughput imaging and omics assays, and establish an open data platform for integrating, visualizing data to build multi-dimensional maps. HuBMAP also intends to build partnerships with other funding agencies, programs, and the biomedical research community.
The HuBMAP recently issued two new Funding Opportunity Announcements (FOAs):
Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3) RFA-RM-17-025
Tissue Mapping Centers for the Human Biomolecular Atlas Program (U54) RFA-RM-17-027
FY18 initiatives for HuBMAP will include Technology Development, Tissue Mapping, and also the HuBMAP Integration, Visualization, and Engagement (HIVE) Collaboratory.
For additional information about HuBMAP activities, including pre-application technical assistance webinars and the HuBMAP mailing list, please visit: https://commonfund.nih.gov/hubmap.
The NIH Common Fund (formerly the NIH Roadmap) encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices.